These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23656263)

  • 1. New circulating tumor cell technology could advance personalized medicine in prostate cancer.
    Miller S
    Nanomedicine (Lond); 2013 May; 8(5):683-4. PubMed ID: 23656263
    [No Abstract]   [Full Text] [Related]  

  • 2. Making personalized prostate cancer medicine a reality: challenges and opportunities in the re-establishment of gold standards.
    Farooqi AA; Butt G; Yousaf G; Qadir MI; Shaukat U; Mansoor Q; Awan M; Bhatti S; Begum A
    Pak J Pharm Sci; 2013 Jul; 26(4):831-40. PubMed ID: 23811467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endothelial cells as biomarkers of prostate cancer.
    Georgiou HD; Namdarian B; Corcoran NM; Costello AJ; Hovens CM
    Nat Clin Pract Urol; 2008 Aug; 5(8):445-54. PubMed ID: 18682720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting the capture efficiency of a filter-based microdevice: a CTC is not a CTC unless it is CD45 negative--letter.
    Attard G; Crespo M; Lim AC; Pope L; Zivi A; de Bono JS
    Clin Cancer Res; 2011 May; 17(9):3048-9; author reply 3050. PubMed ID: 21536548
    [No Abstract]   [Full Text] [Related]  

  • 5. The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer.
    Saad F; Pantel K
    Future Oncol; 2012 Mar; 8(3):321-31. PubMed ID: 22409467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for the diagnosis of new and recurrent prostate cancer.
    Sardana G; Diamandis EP
    Biomark Med; 2012 Oct; 6(5):587-96. PubMed ID: 23075237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of flow cytometry and RT-PCR in the detection of circulating PSA-positive cells in prostate cancer.
    Fadlon EJ; Hamdy FC
    Methods Mol Biol; 1998; 92():215-25. PubMed ID: 9664517
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostate-specific membrane antigen. A new sensitive molecular indicator in metastasizing prostatic cancer].
    Kippersund JT; Haukeland B; Lilleeng BF; Daehlin L; Haukaas S; Høisaeter PA; Ogreid D
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3612-5. PubMed ID: 8539714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A performance analysis of the presence of malignant circulating prostate cells as a predictive factor for the detection of prostate cancer in the first, second and third prostate biopsy.
    Murray NP; Reyes E; Tapia P; Badinez L; Orellana N; Fuentealba C; Olivares R; Dueñas R
    Arch Esp Urol; 2013 May; 66(4):335-41. PubMed ID: 23676536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor cell separation by cell saver and membrane filter passage].
    Wiesel M; Güdemann C; Staehler G
    Infusionstherapie; 1991 Jun; 18(3):143-4. PubMed ID: 1917056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer.
    Gonzales JC; Fink LM; Goodman OB; Symanowski JT; Vogelzang NJ; Ward DC
    Clin Genitourin Cancer; 2011 Sep; 9(1):39-45. PubMed ID: 21723797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine: Catching tumour cells in the zone.
    Leggett SE; Wong IY
    Nat Nanotechnol; 2017 Mar; 12(3):191-193. PubMed ID: 27870839
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate cancer and other xenografts from cells in peripheral blood of patients.
    Pretlow TG; Schwartz S; Giaconia JM; Wright AL; Grimm HA; Edgehouse NL; Murphy JR; Markowitz SD; Jamison JM; Summers JL; Hamlin CR; MacLennan GT; Resnick MI; Pretlow TP; Connell CF
    Cancer Res; 2000 Aug; 60(15):4033-6. PubMed ID: 10945604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
    Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
    Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.
    Ali A; Furusato B; Ts'o PO; Lum ZP; Elsamanoudi S; Mohamed A; Srivastava S; Moul JW; Brassell SA; Sesterhenn IA; McLeod DG
    Pathol Int; 2010 Oct; 60(10):667-72. PubMed ID: 20846264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single Cell Analysis and Circulating Tumor Cells in Prostate Cancer: Experience of an Observership at Cold Spring Harbor Laboratory, CSH and New York Presbyterian Hospital (Cornell Campus), New York.
    Pandey S; Khanna A
    Asian Pac J Cancer Prev; 2015; 16(14):6173-4. PubMed ID: 26320516
    [No Abstract]   [Full Text] [Related]  

  • 18. Limitations of isolated tumor cells in gastric cancer: heterogeneity requests systems biology approaches towards personalized medicine.
    Ziogas DE; Roukos DH
    Ann Surg Oncol; 2010 Jan; 17(1):343-4; author reply 345. PubMed ID: 19841984
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.
    Glinskii AB; Smith BA; Jiang P; Li XM; Yang M; Hoffman RM; Glinsky GV
    Cancer Res; 2003 Jul; 63(14):4239-43. PubMed ID: 12874032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.